Le Lézard
Classified in: Science and technology, Business
Subject: FNC

First Tranche of ?20m European Investment Bank Loan Drawn Today


STOCKHOLM, Feb. 5, 2018 /PRNewswire/ --

Clavister, a leader in high-performance network security solutions, drew its first tranche of funding from the European Investment Bank ("EIB") today under the finance contract dated December 18, 2017 (see related press release of the Summon to the EGM and the Press Conference and EIB signing ceremony). The total sum drawn today is ?10m, out of the total ?20m loan made available to Clavister AB; the remaining two tranches amounts to up to ?5m each. The use of proceeds of the loan is to support Clavister's growth ambitions, investing in further product development and innovation and significantly expanding the company's sales and marketing presence. 

CONTACT:

For more information, please contact:
Håkan Mattisson, CFO Clavister Group
[email protected]

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/clavister/r/first-tranche-of--20m-european-investment-bank-loan-drawn-today,c2445154

The following files are available for download:

http://mb.cision.com/Main/9441/2445154/787072.pdf

PDF

SOURCE Clavister


These press releases may also interest you

at 11:50
CX Circle NYC, an immersive event dedicated to all things Customer Experience (CX), is back in Manhattan on September 10 for its second-ever edition. Presented by Contentsquare, a global leader in Digital Experience Analytics, CX Circle brings...

at 11:43
...

at 11:41
Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, today announced new research outlining the cellular engineering and manufacturing techniques underlying Fertilo, their novel investigational in vitro maturation...

at 11:41
AdRabbit Limited (the "Company")  announces that they are not able to file their annual financial statements, accompanying management's discussion and analysis ("MD&A") and related CEO and CFO certifications for the financial year ended December 31,...

at 11:40
Donaldson Company, Inc. , a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for...

at 11:39
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA. The newly built 154,000-square-foot lab and...



News published on and distributed by: